242 related articles for article (PubMed ID: 8575126)
1. Differences in calcium kinetic pattern between CAPD and HD patients.
Kurz P; Tsobanelis T; Roth P; Werner E; Ewald U; Grützmacher P; Schoeppe W; Vlachojannis J
Clin Nephrol; 1995 Oct; 44(4):255-61. PubMed ID: 8575126
[TBL] [Abstract][Full Text] [Related]
2. Evidence for preservation of cortical bone mineral density in patients on continuous ambulatory peritoneal dialysis.
Mottet JJ; Horber FF; Casez JP; Descoeudres C; Jaeger P
J Bone Miner Res; 1996 Jan; 11(1):96-104. PubMed ID: 8770702
[TBL] [Abstract][Full Text] [Related]
3. Effect of CAPD and hemodialysis on parathyroid function.
Malberti F; Corradi B; Imbasciati E
Adv Perit Dial; 1996; 12():239-44. PubMed ID: 8865912
[TBL] [Abstract][Full Text] [Related]
4. Relationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate.
Cho MS; Lee KS; Lee YK; Ma SK; Ko JH; Kim SW; Kim NH; Choi KC
Korean J Intern Med; 2002 Jun; 17(2):114-21. PubMed ID: 12164088
[TBL] [Abstract][Full Text] [Related]
5. Calcium kinetic studies in patients on CAPD: improvement of secondary hyperparathyroidism without concomitant improvement of calcium turnover.
Kurz P; Tsobanelis T; Brunkhorst R; Roth P; Werner E; Schoeppe W; Vlachojannis J
Perit Dial Int; 1997; 17(1):59-65. PubMed ID: 9068024
[TBL] [Abstract][Full Text] [Related]
6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
7. The sigmoidal parathyroid hormone-ionized calcium curve and the set point of calcium in hemodialysis and continuous ambulatory peritoneal dialysis.
Malberti F; Corradi B; Pagliari B; Romanini D; Gazo A; Sidoti A; Baretta A; Bellazzi R; Imbasciati E
Perit Dial Int; 1993; 13 Suppl 2():S476-9. PubMed ID: 8399645
[TBL] [Abstract][Full Text] [Related]
8. Long-term effect of oral calcitriol single weekly pulse in CAPD and in HD.
Romanini D; Gazo A; Bellazzi R; de Vincenzi A; Nai M; Santagostino M
Adv Perit Dial; 1994; 10():267-9. PubMed ID: 7999842
[TBL] [Abstract][Full Text] [Related]
9. Serum magnesium concentration is an independent predictor of parathyroid hormone levels in peritoneal dialysis patients.
Navarro JF; Mora C; Macia M; Garcia J
Perit Dial Int; 1999; 19(5):455-61. PubMed ID: 11379859
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the humoral markers of bone turnover and bone mineral density in patients on haemodialysis and continuous ambulatory peritoneal dialysis.
Hampson G; Vaja S; Evans C; Chesters CA; Pettit R; Evans W; Thomas D; Seed PT; Fraser WD
Nephron; 2002 May; 91(1):94-102. PubMed ID: 12021525
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of bone mineral density in CAPD patients with dual energy X-ray absorptiometry.
Pasadakis P; Thodis E; Mourvati E; Euthimiadou A; Margaritis D; Manavis J; Vargemezis V
Adv Perit Dial; 1996; 12():245-9. PubMed ID: 8865913
[TBL] [Abstract][Full Text] [Related]
12. Bone biopsy results and serum bone turnover parameters in uremic children.
Ziólkowska H; Pańiczyk-Tomaszewska M; Debiński A; Polowiec Z; Sawicki A; Sieniawska M
Acta Paediatr; 2000 Jun; 89(6):666-71. PubMed ID: 10914959
[TBL] [Abstract][Full Text] [Related]
13. [Renal osteodystrophy in dialysis patients as estimated by three-point bone densitometry].
Kucharska E; Stompór T; Sułowicz W; Drozdz M; Kaczmarczyk I; Szymczakiewicz-Multanowska A; Chruściel B; Kraśnicka M
Przegl Lek; 2000; 57(6):334-9. PubMed ID: 11107868
[TBL] [Abstract][Full Text] [Related]
14. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
Tuzcu A; Bahceci M; Yilmaz ME; Turgut C; Kara IH
Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871
[TBL] [Abstract][Full Text] [Related]
15. Bone histology in CAPD patients: a comparison with hemodialysis and conservatively treated chronic uremics.
Joffe P; Pódenphant J; Heaf JG
Adv Perit Dial; 1989; 5():171-6. PubMed ID: 2577405
[TBL] [Abstract][Full Text] [Related]
16. Bone disease in predialysis, hemodialysis, and CAPD patients: evidence of a better bone response to PTH.
Torres A; Lorenzo V; Hernández D; Rodríguez JC; Concepción MT; Rodríguez AP; Hernández A; de Bonis E; Darias E; González-Posada JM
Kidney Int; 1995 May; 47(5):1434-42. PubMed ID: 7637272
[TBL] [Abstract][Full Text] [Related]
17. Low turnover bone disease is the more common form of bone disease in CAPD patients.
Rodriguez-Perez JC; Plaza C; Torres A; Vega N; Anabitarte A; Fernandez A; Lorenzo V; Hortal L; Palop L
Adv Perit Dial; 1992; 8():376-80. PubMed ID: 1361827
[TBL] [Abstract][Full Text] [Related]
18. Renal osteodystrophy in Ramathibodi Hospital: histomorphometry and clinical correlation.
Changsirikulchai S; Domrongkitchaiporn S; Sirikulchayanonta V; Ongphiphadhanakul B; Kunkitti N; Stitchantrakul W; Radienahamed P
J Med Assoc Thai; 2000 Oct; 83(10):1223-32. PubMed ID: 11143489
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis.
Qi Q; Monier-Faugere MC; Geng Z; Malluche HH
Am J Kidney Dis; 1995 Oct; 26(4):622-31. PubMed ID: 7573017
[TBL] [Abstract][Full Text] [Related]
20. Does parathyroid hormone affect erythropoietin therapy in dialysis patients?
Al-Hilali N; Al-Humoud H; Ninan VT; Nampoory MR; Puliyclil MA; Johny KV
Med Princ Pract; 2007; 16(1):63-7. PubMed ID: 17159367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
